SEARCH BY

Issuer directory Issuer directory
KEYWORDS
COMPANIES / ISIN
TYPE OF INFORMATION
INDUSTRY

Start search  ADVANCED SEARCH

COMPARTMENTS / INDICES

France
America
Asia
Oceania
Africa
Europe

MSI NEWS

FEEDS

My RSS My Google Microsoft Live My Yahoo

COMPANY SEARCH RESULT

VIFOR PHARMA: Click to view the issuer\'s details

Last update : 21/08/2018  >View issuer details

2019.01.22 | 06:00 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Updated Analysis of Pivotal Study Reveals: Proactive, High Dosage of Venofer® Significantly Reduces Risk of Death or Major Cardiovascular Events in Haemodialysis Patients - HTML (w)

2019.01.07 | 06:00 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Vifor Pharma receives positive phase-I trial results for oral ferroportin inhibitor - HTML (w)

2019.01.07 | 06:00 | Permanent Information Releases / General Company News

French version HTML (w) Mail

puce Vifor Pharma obtient des résultats d’essai de phase I positifs pour l’inhibiteur de la ferroportine administré par voie orale - HTML (w)

2018.12.12 | 06:00 | Permanent Information Releases / Appointments

English version HTML (w) Mail

puce Patrick Treanor appointed President of Relypsa and member of the Executive Committee of Vifor Pharma Group - HTML (w)

2018.11.26 | 06:00 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce 2018 Iron Deficiency Day: A Call to Develop a Better Understanding of Iron Deficiency - HTML (w)

2018.08.08 | Periodic information / Half-Year Financial Report

English version PDF Mail

puce VIFOR PHARMA : HALF-YEAR REPORT 2018 - PDF (746Kb)

2018.03.13 | Periodic information / Annual Financial Report

English version PDF Mail

puce VIFOR PHARMA : ANNUAL REPORT 2017 - PDF (6Mb)